Regulators and mediators of the p53 tumor suppressor

Journal of Cellular Biochemistry

Volumn , Issue SUPPL. 30/31, 1998, Pages 43-49

  Cadwell, Craig ^a   Zambetti, Gerard P ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Angiogenesis; p53; Signal transduction; Tumor suppression

Indexed keywords

PROTEIN P53; REPRESSOR PROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER GROWTH; GENE DELETION; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANIMAL; GENETICS; PHYSIOLOGY; REGULATORY SEQUENCE; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION; GENES, P53; HUMANS; REGULATORY SEQUENCES, NUCLEIC ACID; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 0032416021     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4644(1998)72:30/31+<43::aid-jcb7>3.3.co;2-v     Document Type: Article

References (29)

1. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM (1998): Stabilization of wild-type p53 by hypoxia-inducible factor lα. Nature 392:405-408.
2. Bouvet M, Ellis L, Nishizaki M, Fujiwara T, Liu W, Bucana C, Fang B, Lee JJ, Roth JA (1998): Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res 58:2288-2292.
3. Canman CE, Gilmer TM, Coutts SB, Kastan MB (1995): Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 9:600-611.
4. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brussel-mans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshet E (1998): Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485-490.
5. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994): Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582-1584.
6. arf tumor suppressor. Genes Dev 12:2434-2442.
7. Folkman J (1974): Tumor angiogenesis. Adv Cancer Res 19:331-358.
8. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, Felley-Bosco E, Wang XW, Geller DA, Tzeng E, Billiar TR, Harris CC (1996): Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA 93:2442-2447.
9. Frazier MW, He X, Wang J, Gu Z, Cleveland J, Zambetti GP (1998): Activation of c-myc gene expression by tumor-derived p53 mutants require a discrete C-terminal domain. Mol Cell Biol 18:3735-3743.
10. ING1 promotes neoplastic transformation. Nature Genet 14:415-420.
11. Giaccia AJ, Kastan MB (1998): The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12:2973-2983.
12. Graeber AJ, Osmanian C, Jack T, Housman DE, Koch CJ, Lowe SW, Graccia AJ (1996): Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88-91.
13. Hanahan D, Folkman J (1996): Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
14. Haupt Y, Maya R, Kazaz A, Oren M (1997): Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
15. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC (1994): Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22:3551-3555.
16. Isaacs JS, Hardman R, Carman TA, Barrett JC, Weissman BE (1998): Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines. Cell Growth Diff 9:545-555.
17. ARF. Cell 91:649-659.
18. Kamijo T, Weber JD, Zambetti GP, Zindy F, Roussel MF, Sherr CJ (1998): Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci USA 95:8292-8297.
19. Kang S-M, Maeda K, Onoda N, Chung Y-S, Nakata B, Nishiguchi Y, Sowa M (1997): Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer 74:502-507.
20. Mukhopadhyay D, Tsiokas L, Sukhatme VP (1995): Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55:6161-6165.
21. Packham G, White EL, Eischen CM, Yang H, Parganas E, Ihle JN, Grillot DAM, Zambetti GP, Nunez G, Cleveland JL (1998): Selective regulation of bcl-XL by a jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev 12:2475-2487.
22. Pietenpol JA, Vogelstein B (1993): Tumour suppressor genes. No room at the p53 inn. Nature 365:17-18.
23. Polayk K, Xia Y, Zweir JL, Kinzler KW, Vogelstein B (1997): A model for p53-induced apoptosis. Nature 389:300-305.
24. Quelle DE, Zindy F, Ashmun RA, Sherr CJ (1995): Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993-1000.
25. Quelle FW, Wang JL, Feng J, Wang D, Cleveland JL, Ihle JN, Zambetti GP (1998): Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways. Genes Dev 12:1099-1107.
26. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson C, Appella E (1998): DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12:2831-2841.
27. Sherr CJ (1996): Cancer cell cycles. Science 274:1672-1677.
28. Takahashi Y, Bucana CD, Cleary KR, Ellis LM (1998): p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int J Cancer 79:34-38.
29. Van Meir EG, Polverini PJ, Chazin VR, Su Huang H-J, de Tribolet N, Cavenee WK (1994): Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genet 8:171-176.